Capital World Investors Portfolio holdings
Capital World Investors (CWI), a division of Capital Group, one of the oldest and largest investment management firms in the world, was established in 1931 and is headquartered in Los Angeles, California. Specializing in active investment management, CWI focuses on long-term growth through a research-intensive approach, managing hundreds of billions in assets primarily through equity-focused mutual funds and institutional portfolios. It serves a diverse client base, including individual investors, financial advisors, and institutions, and is known for its flagship funds like the American Funds, which emphasize fundamental analysis and a multiple-portfolio-manager system to mitigate risk. With a global reach and a reputation for disciplined, value-oriented investing, CWI remains a cornerstone of Capital Group’s mission to deliver consistent, superior returns.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.36B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$5B |
| 3 |
Amazon
AMZN
|
+$3.67B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.6B |
| 5 |
TotalEnergies
TTE
|
+$3.2B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$6.34B |
| 2 |
Synopsys
SNPS
|
+$3.12B |
| 3 |
Cloudflare
NET
|
+$2.5B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.36B |
| 5 |
Broadcom
AVGO
|
+$2.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 13.18% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
PepsiCo
PEP
$190B
| $210M | 0.03% |
1,352,316
+991,880
| +275% | +$155M |
|
|
KKR.PRD
302
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.29B
| $209M | 0.03% |
5,207,215
| – | – |
|
303
Arcosa
ACA
$7.11B
| $209M | 0.03% |
1,970,776
+290,776
| +17% | +$33.1M |
|
304
Ascendis Pharma A/S
ASND
$16.8B
| $206M | 0.03% |
+900,517
| New | +$202M |
|
305
Interactive Brokers
IBKR
$39.8B
| $203M | 0.03% |
+3,030,920
| New | +$216M |
|
306
Sempra
SRE
$54.8B
| $203M | 0.03% |
+2,088,465
| New | +$191M |
|
307
Celanese
CE
$4.82B
| $201M | 0.03% |
3,050,791
+1,765,922
| +137% | +$92.2M |
|
308
Amphenol
APH
$209B
| $196M | 0.03% |
+1,553,787
| New | +$219M |
|
309
Transocean
RIG
$5.82B
| $196M | 0.03% |
29,575,479
+13,909,743
| +89% | +$78.3M |
|
310
New York Times
NYT
$10.2B
| $196M | 0.03% |
+2,339,543
| New | +$177M |
|
311
Saia
SAIA
$9.72B
| $195M | 0.03% |
555,352
+148,087
| +36% | +$54M |
|
312
Corning
GLW
$143B
| $194M | 0.03% |
+1,423,400
| New | +$172M |
|
|
CNTA
313
DELISTED
Centessa Pharmaceuticals
CNTA
| $192M | 0.03% |
4,832,548
+3,673,849
| +317% | +$94M |
|
|
MDLN
314
Medline Inc
MDLN
$30.9B
| $192M | 0.03% |
4,311,124
+919,547
| +27% | +$40.6M |
|
|
NVO
315
Novo Nordisk
NVO
$209B
| $191M | 0.03% |
5,209,427
+5,010,064
| +2,513% | +$237M |
|
316
Iron Mountain
IRM
$36.1B
| $191M | 0.03% |
1,867,169
-250,000
| -12% | -$24.9M |
|
317
Vista Energy
VIST
$7.32B
| $189M | 0.03% |
2,500,977
+21,372
| +0.9% | +$1.25M |
|
|
CSW
318
CSW Industrials
CSW
$5.71B
| $187M | 0.03% |
716,049
-336,431
| -32% | -$97.8M |
|
|
GRFS
319
Grifois
GRFS
$5.4B
| $184M | 0.03% |
22,924,990
| – | – |
|
320
S&P Global
SPGI
$120B
| $181M | 0.02% |
+425,661
| New | +$198M |
|
321
Freshpet
FRPT
$3.22B
| $176M | 0.02% |
2,985,886
+1,398,195
| +88% | +$98.2M |
|
322
C.H. Robinson
CHRW
$17.5B
| $173M | 0.02% |
1,041,892
+9,446
| +0.9% | +$1.69M |
|
323
CAVA Group
CAVA
$7.27B
| $172M | 0.02% |
2,126,860
+1,643,758
| +340% | +$120M |
|
324
Idacorp
IDA
$8.2B
| $170M | 0.02% |
+1,186,800
| New | +$163M |
|
325
Celestica
CLS
$36.5B
| $169M | 0.02% |
600,225
-32,218
| -5% | -$9.35M |
|
Similar funds
Capital World Investors's Q1 2026 Portfolio in Review
As of Q1 2026, Capital World Investors held 676 positions worth $733B, down 0.32% from $735B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital World Investors deployed $25.6B of net new capital in Q1 2026, opening 108 new positions and adding to 262 existing holdings. Its largest new stake was Akamai: 6,764,438 shares worth $777M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $6.34B trimmed.
- Capital World Investors's largest Q1 2026 buy was Akamai: 6,764,438 shares worth $777M.
- Capital World Investors added most to AstraZeneca in Q1 2026, an estimated $5.36B increase.
- Capital World Investors's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $6.34B.
- Capital World Investors fully exited Synopsys in Q1 2026, selling an estimated $3.12B.
- Capital World Investors's ten largest holdings make up 28% of its $733B portfolio in Q1 2026.
- Capital World Investors opened 108 new positions and closed 56 in Q1 2026.
- Capital World Investors's portfolio value fell 0.32% quarter-over-quarter to $733B.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.